Sign up
Quantellect · Analysts · Analyst Profile
Q Score Rank#323 of 449

Constantine Davides

EF Hutton · Equity Research Analyst
ProvisionalRating since 2021No new ratings since Jun 2023

Analyst rating accuracy & track record

Constantine Davides is an equity research analyst at EF Hutton. Quantellect has scored 25 of their stock calls across 10 companies. Their picks beat their sector 42% of the time over the next 12 months, and their price targets were reached 31% of the time within a year.

Win % vs sector
42%
PT Hit % (12mo)
31%
Avg sector-excess
−12.3%
Scored calls
25
Tickers
10
Tier
Provisional

Track record

Quantellect has scored 25 of Constantine Davides's stock calls across 10 companies, dating back to 2021. Their rated stocks beat their own sector 42% of the time over the next 12 months. On a typical call, a Davides pick returned −12.3% more than its sector over the following year.

Of the scored calls, 25 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
NNVCNanoViricides Inc
Buy$5.25Jun 2023+78.4%Miss
ELMDElectromed Inc
Buy$15.00May 2023+33.2%Hit
INVAInnoviva Inc
Buy$22.50May 2023+13.0%Miss
CCLDCareCloud, Inc.
Buy$8.50May 2023−72.9%Miss
INVAInnoviva Inc
Buy$22.50Apr 2023+19.6%Miss
HCWBHCW Biologics Inc
Buy$9.00Apr 2023+15.7%Miss
NNVCNanoViricides Inc
Buy$5.25Apr 2023−21.6%Miss
BBLGBone Biologics Corp
Buy$2.25Apr 2023−102.0%Miss
BBLGBone Biologics Corp
Buy$2.25Apr 2023−108.9%Miss
KTTAPasithea Therapeutics Corp
Buy$2.00Apr 2023−21.6%Miss
HCWBHCW Biologics Inc
Buy$9.00Mar 2023+2.8%Miss
HCWBHCW Biologics Inc
Buy$9.00Mar 2023+9.8%Miss
CCLDCareCloud, Inc.
Buy$8.50Mar 2023−79.2%Miss
INVAInnoviva Inc
Buy$22.50Mar 2023+23.4%Miss
NNVCNanoViricides Inc
Buy$5.25Feb 2023−16.2%Miss
ELMDElectromed Inc
Buy$15.00Feb 2023−9.4%Miss
BBLGBone Biologics Corp
Buy$2.25Oct 2022−101.8%Miss
HCTIHealthcare Triangle Inc
Buy$2.00Sep 2022−13.7%Miss
BIVIBiovie Inc
Buy$8.00Sep 2022+24.2%Hit
ISPCiSpecimen Inc
Buy$4.25Sep 2022−74.3%Miss
ELMDElectromed Inc
Buy$13.50Sep 2022+3.0%Hit
BIVIBiovie Inc
Buy$14.00Mar 2022+154.6%Hit
HCTIHealthcare Triangle Inc
Buy$4.00Mar 2022−60.6%Miss
KTTAPasithea Therapeutics Corp
Buy$3.25Dec 2021−60.9%Miss
ISPCiSpecimen Inc
Buy$12.00Nov 2021−92.7%Hit
Prev1Next
Go to

Constantine Davides: analyst track record FAQ

Is Constantine Davides a good stock analyst?

Yes, by track record. Constantine Davides ranks number 323 of 449 of the analysts Quantellect scores, with a Q Score of 13 out of 100. Past results do not guarantee future ones.

What is Constantine Davides's win rate?

Constantine Davides's win rate is 42%. Across 25 scored calls, their rated stocks beat their sector 42% of the time over the next 12 months. On a typical call they returned −12.3% more than the sector.

What stocks and sectors does Constantine Davides cover?

Constantine Davides covers 10 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Constantine Davides's price targets accurate?

Constantine Davides's price targets are reached within 12 months 31% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Constantine Davides's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Constantine Davides rank among Wall Street analysts?

Constantine Davides ranks number 323 of 449 by Q Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.